Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2020 056 677.5 |
96 | EP file number | EAKZ | 20 86 5925.0 |
86 | WO file number | WAKZ | PCT/US2020/051645 |
97 | EP publication number | EPN | 4031133 |
87 | WO publication number | WPN | 2021055863 |
54 | Designation/title | TI | PYRUVATKINASE R (PKR)-AKTIVIERUNGSZUSAMMENSETZUNGEN |
51 | IPC main class | ICM (ICMV) | A61K 31/407 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/436 (2006.01), A61P 7/06 (2006.01), C07D 487/04 (2006.01), A61K 9/00 (2006.01), A61K 9/16 (2006.01), A61K 9/20 (2006.01), C07D 519/00 (2006.01) |
22 | DE application date | DAT | Sep 18, 2020 |
96 | EP application date | EAT | Sep 18, 2020 |
86 | WO application date | WAT | Sep 18, 2020 |
43 | Date of first publication | OT | Mar 25, 2021 |
| Date of publication of grant | PET | Aug 13, 2025 |
71/73 | Applicant/owner | INH | Novo Nordisk Health Care AG, Zürich, CH |
72 | Inventor | IN | BABU, Suresh, Watertown, MA 02472, US; SHETH, Pratik, Watertown, 02472, US; TALADI, Vijay, Somerset, 08873, US; MITCHELL MINIKIS, Ryan, Somerset, 08873, US |
| Address for service | | Novo Nordisk Health Care AG, 8058 Zürich, CH |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 202062704785 P May 28, 2020
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201962902887 P Sep 19, 2019
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 202062705106 P Jun 11, 2020
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 202063024432 P May 13, 2020
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 202063024441 P May 13, 2020
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201962906437 P Sep 26, 2019
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| WO PCT/US2019/052024 Sep 19, 2019
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201916576360 Sep 19, 2019
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201916576720 Sep 19, 2019
|
| Due date | FT FG | Sep 30, 2025 Annual fee for the 6th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000004031133A1 Searchable text:
EP000004031133A1 Original document:
EP000004031133B1 Searchable text:
EP000004031133B1 Original document:
WO002021055863 Searchable text:
WO002021055863 |
43 | Date of first publication | EVT | Mar 25, 2021 |
| Date of the first transfer into DPMAregister | EREGT | Jul 27, 2022 |
| Date of the (most recent) update in DPMAregister | REGT | Jul 24, 2025 (Show all update days)(Hide all update days)- Jul 24, 2025
- Applicant/owner: new
- Address for service: new
- Due date: new
- Jul 23, 2025
- DE file number : new
- DE application date: new
- Date of publication of grant: new
- Foreign priority: new
- Published EP/WO documents: changed
- File number displayed in the result list: changed
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 13.08.2025: new
- Nov 13, 2024
- Jul 27, 2022
- Date of the first transfer into DPMAregister
|